⌘K

Home/Filings/4/0000939798-20-000007

4//SEC Filing

Cataldo Tony 4

Accession 0000939798-20-000007

CIK 0000109657other

View on SEC.gov Company Profile

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 5:15 PM ET

Size

4.9 KB

Accession

0000939798-20-000007

Insider Transaction Report

Form 4

Period: 2020-06-02

GT Biopharma, Inc.GTBP

DirectorChairman and CEO

Transactions

Sale
common stock
2020-06-02$0.00/sh−4,234,320$4,234→ 6,500,000 total

Footnotes (1)

[F1]The disposal of the 4,234,320 shares was made to satisfy obligations pursuant to the terms of a Stock Pledge Agreement signed on August 1, 2018.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

GT Biopharma, Inc.

CIK 0000109657

Entity typeother

Related Parties

1

filerCIK 0001450565

Filing Metadata

Form type: 4
Filed: Jun 3, 8:00 PM ET
Accepted: Jun 4, 5:15 PM ET
Size: 4.9 KB

View on SEC.gov